Immunovia IMMVF Stock
Immunovia Price Chart
Immunovia IMMVF Financial and Trading Overview
| Immunovia stock price | 0.0100 USD |
| Previous Close | 0.01 USD |
| Open | 0.15 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.15 - 0.15 USD |
| 52 Week Range | 0.01 - 0.15 USD |
| Volume | 325 USD |
| Avg. Volume | 62 USD |
| Market Cap | 6.73M USD |
| Beta (5Y Monthly) | 2.726 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IMMVF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Immunovia Stock Price History
| Beta (5Y Monthly) | 2.726 |
| 52-Week Change | -80.79% |
| S&P500 52-Week Change | 15.77% |
| 52 Week High | 0.15 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
IMMVF Share Statistics
| Avg. Volume (3 month) | 62 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 672.67M |
| Float | 619.73M |
| Short Ratio | N/A |
| % Held by Insiders | 9.77% |
| % Held by Institutions | 16.89% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 56.97% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -124.89% |
| Return on Equity (ttm) | -426.96% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 323.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -83221000 USD |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 13.84 USD |
| Current Ratio (mrq) | 1.57 |
| Book Value Per Share (mrq) | -0.027 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | -40291124 USD |
Profile of Immunovia
| Country | United States |
| State | N/A |
| City | Lund |
| Address | Medicon Village |
| ZIP | 223 63 |
| Phone | 46 4 62 75 60 00 |
| Website | https://www.immunovia.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 18 |
Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Q&A For Immunovia Stock
What is a current IMMVF stock price?
Immunovia IMMVF stock price today per share is 0.0100 USD.
How to purchase Immunovia stock?
You can buy IMMVF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immunovia?
The stock symbol or ticker of Immunovia is IMMVF.
Which industry does the Immunovia company belong to?
The Immunovia industry is Diagnostics & Research.
How many shares does Immunovia have in circulation?
The max supply of Immunovia shares is 672.67M.
What is Immunovia Price to Earnings Ratio (PE Ratio)?
Immunovia PE Ratio is now.
What was Immunovia earnings per share over the trailing 12 months (TTM)?
Immunovia EPS is -0.01 USD over the trailing 12 months.
Which sector does the Immunovia company belong to?
The Immunovia sector is Healthcare.
